Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice

Cancer Science

Volumn 106, Issue 9, 2015, Pages 1143-1152

  Okada, Hikari ^a   Honda, Masao ^a,b   Campbell, Jean S ^c   Takegoshi, Kai ^a   Sakai, Yoshio ^a   Yamashita, Taro ^a   Shirasaki, Takayoshi ^a   Takabatake, Riuta ^a   Nakamura, Mikiko ^a   Tanaka, Takuji ^d   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Cancer Research and Prevention   (Japan)

Author keywords

Hepatic fibrosis; Hepatocellular carcinoma; Locked nucleic acid; MicroRNA; Platelet derived growth factor C

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INVIVOFECTAMINE; LOCKED NUCLEIC ACID; MICRORNA 214; MIG 6 PROTEIN; PLATELET DERIVED GROWTH FACTOR C; PROTEIN; REAGENT; SCATTER FACTOR RECEPTOR; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR; LYMPHOKINE; MICRORNA; OLIGONUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; CANCER INCIDENCE; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; CONTROLLED STUDY; FIBROGENESIS; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEATOSIS; STELLATE CELL; TAIL VEIN; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; HEK293 CELL LINE; HEPG2 CELL LINE; INCIDENCE; LIVER; LIVER CIRRHOSIS; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; HEK293 CELLS; HEP G2 CELLS; HUMANS; INCIDENCE; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHOKINES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; OLIGONUCLEOTIDES; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84942200216     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12730     Document Type: Article

References (30)

1. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010; 7: 425-36.
2. Campbell JS, Hughes SD, Gilbertson DG et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A 2005; 102: 3389-94.
3. Okada H, Honda M, Campbell JS et al. Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res 2012; 72: 4459-71.
4. Esquela-Kerscher A, Slack FJ. Oncomirs - MicroRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
5. He Y, Huang C, Zhang SP, Sun X, Long XR, Li J. The potential of microRNAs in liver fibrosis. Cell Signal 2012; 24: 2268-72.
6. Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Kaneko S. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology 2006; 44: 1122-38.
7. Ura S, Honda M, Yamashita T et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49: 1098-112.
8. Shinoda M, Tilles AW, Kobayashi N et al. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res 2007; 137: 130-40.
9. Pfeifer AM, Cole KE, Smoot DT et al. Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci U S A 1993; 90: 5123-7.
10. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
11. Matsuzawa N, Takamura T, Kurita S et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007; 46: 1392-403.
12. Safdar H, Cheung KL, Vos HL et al. Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4alpha and C/EBPalpha. PLoS ONE 2012; 7: e38104.
13. Reschke M, Ferby I, Stepniak E et al. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma. Hepatology 2010; 51: 1383-90.
14. Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 2007; 450: 741-4.
15. Janssen HL, Reesink HW, Lawitz EJ et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-94.
16. Dolganiuc A, Petrasek J, Kodys K et al. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res 2009; 33: 1704-10.
17. Li WQ, Chen C, Xu MD et al. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J 2011; 278: 1522-32.
18. Chen L, Charrier A, Zhou Y et al. Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 2013; 59: 1118-29.
19. Maes OC, An J, Sarojini H, Wang E. Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 2008; 129: 534-41.
20. Yamashita T, Honda M, Nakamoto Y et al. Discrete nature of EpCAM+ and CD90 + cancer stem cells in human hepatocellular carcinoma. Hepatology 2013; 57: 1484-97.
21. van Balkom BW, de Jong OG, Smits M et al. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 2013; 121: 3997-4006, S1-15.
22. Maubach G, Lim MC, Chen J, Yang H, Zhuo L. miRNA studies in in vitro and in vivo activated hepatic stellate cells. World J Gastroenterol 2011; 17: 2748-73.
23. Chen C, Wu CQ, Zhang ZQ, Yao DK, Zhu L. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res 2011; 317: 1714-25.
24. Denby L, Ramdas V, Lu R et al. MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc Nephrol 2014; 25: 65-80.
25. Fuchs BC, Hoshida Y, Fujii T et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 2014; 59: 1577-90.
26. Xu WH, Hu HG, Tian Y et al. Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis. Hepatology 2014; 60: 648-60.
27. Yang H, Kong W, He L et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008; 68: 425-33.
28. Xu CX, Xu M, Tan L et al. MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. J Biol Chem 2012; 287: 34970-8.
29. Ueda T, Volinia S, Okumura H et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010; 11: 136-46.
30. Shih TC, Tien YJ, Wen CJ et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012; 57: 584-91.